Abstract
Transforming growth factor-β (TGF-β) signaling is mediated by a complex of type I (TBRI) and type II (TBRII) receptors. The type III receptor (TBRIII) lacks a recognizable signaling domain and has no dearly defined role in TGF-β signaling. Cardiac endothelial cells that undergo epithelial- mesenchymal transformation express TBRIII, and here TBRIII-specific antisera were found to inhibit mesenchyme formation and migration in atrioventricular cushion explants. Misexpression of TBRIII in nontransforming ventricular endothelial ceils conferred transformation in response to TGF-β2. These results support a model where TBRIII localizes transformation in the heart and plays an essential, nonredundant role in TGF-β signaling.
Original language | English (US) |
---|---|
Pages (from-to) | 2080-2082 |
Number of pages | 3 |
Journal | Science |
Volume | 283 |
Issue number | 5410 |
DOIs | |
State | Published - Mar 26 1999 |
ASJC Scopus subject areas
- General